Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer
Mosele, F., Stefanovska, B., Lusque, A., Tran Dien, A., Garberis, I., Droin, N., Le Tourneau, C., Sablin, M.-P., Lacroix, L., Enrico, D., Miran, I., Jovelet, C., Bièche, I., Soria, J.-C., Bertucci, F., Bonnefoi, H., Campone, M., Dalenc, F., Bachelot, T., Jacquet, A., Jimenez, M., André, F.
Published in Annals of oncology (01.03.2020)
Published in Annals of oncology (01.03.2020)
Get full text
Journal Article
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population
Turner, N.C., Alarcón, E., Armstrong, A.C., Philco, M., López Chuken, Y.A., Sablin, M.-P., Tamura, K., Gómez Villanueva, A., Pérez-Fidalgo, J.A., Cheung, S.Y.A., Corcoran, C., Cullberg, M., Davies, B.R., de Bruin, E.C., Foxley, A., Lindemann, J.P.O., Maudsley, R., Moschetta, M., Outhwaite, E., Pass, M., Rugman, P., Schiavon, G., Oliveira, M.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial
Belin, L., Kamal, M., Mauborgne, C., Plancher, C., Mulot, F., Delord, J.-P., Gonçalves, A., Gavoille, C., Dubot, C., Isambert, N., Campone, M., Trédan, O., Ricci, F., Alt, M., Loirat, D., Sablin, M.-P., Paoletti, X., Servois, V., Le Tourneau, C.
Published in Annals of oncology (01.03.2017)
Published in Annals of oncology (01.03.2017)
Get full text
Journal Article
Sequential sorafenib and sunitinib for renal cell carcinoma
Sablin, M P, Negrier, S, Ravaud, A, Oudard, S, Balleyguier, C, Gautier, J, Celier, C, Medioni, J, Escudier, B
Published in The Journal of urology (01.07.2009)
Published in The Journal of urology (01.07.2009)
Get more information
Journal Article
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival
Dubot, C., Bernard, V., Sablin, M.P., Vacher, S., Chemlali, W., Schnitzler, A., Pierron, G., Ait Rais, K., Bessoltane, N., Jeannot, E., Klijanienko, J., Mariani, O., Jouffroy, T., Calugaru, V., Hoffmann, C., Lesnik, M., Badois, N., Berger, F., Le Tourneau, C., Kamal, M., Bieche, I.
Published in European journal of cancer (1990) (01.03.2018)
Published in European journal of cancer (1990) (01.03.2018)
Get full text
Journal Article
Single agent and combination studies of pralatrexate and molecular correlates of sensitivity
Serova, M, Bieche, I, Sablin, M-P, Pronk, G J, Vidaud, M, Cvitkovic, E, Faivre, S, Raymond, E
Published in British journal of cancer (18.01.2011)
Published in British journal of cancer (18.01.2011)
Get full text
Journal Article
Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma
Daveau, C, Baulies, S, Lalloum, M, Bollet, M, Sigal-Zafrani, B, Sastre, X, Vincent-Salomon, A, Tardivon, A, Thibault, F, Pierga, J Y, Cottu, P, Sablin, M P, Rouzier, R, Malhaire, C, Mallon, P, Reyal, F
Published in British journal of cancer (29.04.2014)
Published in British journal of cancer (29.04.2014)
Get full text
Journal Article
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets
Moreira, A., Masliah-Planchon, J., Callens, C., Vacher, S., Lecerf, C., Frelaut, M., Borcoman, E., Torossian, N., Ricci, F., Hescot, S., Sablin, M.P., Tresca, P., Loirat, D., Melaabi, S., Trabelsi-Grati, O., Pierron, G., Gentien, D., Bernard, V., Vincent Salomon, A., Servant, N., Bieche, I., Le Tourneau, C., Kamal, M.
Published in European journal of cancer (1990) (01.11.2019)
Published in European journal of cancer (1990) (01.11.2019)
Get full text
Journal Article
Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy
Baulies, S, Belin, L, Mallon, P, Senechal, C, Pierga, J-Y, Cottu, P, Sablin, M-P, Sastre, X, Asselain, B, Rouzier, R, Reyal, F
Published in British journal of cancer (30.06.2015)
Published in British journal of cancer (30.06.2015)
Get full text
Journal Article
First line hormone therapy vs chemotherapy for HR+ HER2- metastatic breast cancer in the phase III STIC CTC trial: clinical choice and validity of CTC count
Bidard, F.-C., Brain, E., Jacot, W., Bachelot, T., Ladoire, S., Bourgeois, H., Gonçalves, A., Naman, H., Gligorov, J., Dalenc, F., Levy, C., Espie, M., Ferrero, J.-M., Luporsi, E., Sablin, M.-P., Dubot, C., Chevrier, M., Berger, F., Alix-Panabieres, C., Pierga, J.-Y.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Patient-specific circulating tumor DNA detection during neoadjuvant chemotherapy in triple negative breast cancer
Pierga, J.-Y., Riva, F., Houy, A., Saliou, A., Madic, J., Rampanou, A., Hego, C., Milder, M., Cottu, P., Sablin, M.-P., Vincent-Salomon, A., Lantz, O., Stern, M.-H., Proudhon, C., Bidard, F.-C.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer
Schmid, Peter, Sablin, Marie-Paule, Bergh, Jonas, Im, Seock-Ah, Lu, Yen-Shen, Martínez, Noelia, Neven, Patrick, Lee, Keun Seok, Morales, Serafín, Pérez-Fidalgo, J Alejandro, Adamson, Douglas, Gonçalves, Anthony, Prat, Aleix, Jerusalem, Guy, Schlieker, Laura, Espadero, Rosa-Maria, Bogenrieder, Thomas, Huang, Dennis Chin-Lun, Crown, John, Cortés, Javier
Published in Breast cancer research : BCR (15.01.2021)
Published in Breast cancer research : BCR (15.01.2021)
Get full text
Journal Article
Web Resource
1282PDissociated responses in patients with metastatic solid tumours treated with immunotherapy
Vaflard, P, Paoletti, X, Servois, V, Pons-Tostivint, E, Sablin, M P, Ricci, F, Loirat, D, Hescot, S, Torossian, N, Borcoman, E, Le Tourneau, C
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
75P Tumor mutational burden in clinical routine practice: Identifying the right threshold?
Dupain, C., Gutman, T., Girard, E., du Rusquec, P., Sablin, M-P., Tresca, P., Neuzillet, C., Vincent-Salomon, A., Antonio, S., Franck, C., Galut, M., Allory, Y., Cyrta, J., Guillou, I., Wong, J., Le Tourneau, C., Bièche, I., Servant, N., Kamal, M., Masliah-Planchon, J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
97PReanalysis of the efficacy of molecular targeted agents (MTAs) given in the randomized trial SHIVA01 according to the ESMO ESCAT scale of actionability
Moreira, A, Vacher, S, Lecerf, C, Frelaut, M, Sablin, M P, Loirat, D, Ricci, F, Hescot, S, Borcoman, E, Torossian, N, Masliah-Planchon, J, Callens, C, Salomon, A, Bieche, I, Le Tourneau, C, Kamal, M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A phase Ib trial of xentuzumab and abemaciclib in patients with locally advanced or metastatic solid tumors, hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer (BC; +/- endocrine therapy), or non-small-cell lung cancer (NSCLC)
Yee, D., Prat, A., Sablin, M.P., Iwata, H., Johnston, E.L., Bogenrieder, T., Serra, J., Hua, H., LoRusso, P.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
Abstract P4-01-20: Circulating tumor DNA as a predictive biomarker of response to palbociclib-fulvestrant in patients with estrogen receptor-positive, HER2-negative metastatic breast cancer
Darrigues, L, Pierga, J-Y, Bernard, A, Bièche, I, Silveira, A, Michel, M, Sablin, M-P, Cottu, P, Dubot, C, Geiss, R, Ricci, F, Proudhon, C, Bidard, F-C
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article